Tourmaline Bio, Inc. (TRML) - Earnings growth in current year
Tourmaline Bio, Inc. (TRML) relies on an asset-light model, outsourcing antibody production to third-party contractors to ensure supply stability. The annual EPS change metric visualizes profit dynamics, with the value holding at -27.20. Tourmaline Bio, Inc. is strengthening its scientific authority in thyroid therapy, planning the launch of final trials for drugs treating cardiopathies and endocrine ophthalmopathies.
Analytical breakdowns and data insights for company Tourmaline Bio, Inc. (TRML)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Aggregate Debt to Capital Tourmaline Bio, Inc.|TRML - Long-Term Debt to Equity|Current Liabilities to Capital tourmalinebio.com|TRML - Company Total Debt|Debts to Book Capitalization Tourmaline|TRML - Company Long-Term Debt|Company Short-Term Loans and Borrowings Tourmaline Bio|Quick Liquidity Indicator tourmalinebio.com
- earnings and market ratios statistics:
TRML - Net Profit|Projected Future Earnings Tourmaline Bio, Inc.|TRML - Price to Earnings Ratio|Future Price to Earnings Tourmaline|TRML - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Tourmaline|TRML - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Tourmaline Bio|TRML - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months tourmalinebio.com|TRML - Net earnings per share growth this year|Expected earnings per share trend next year Tourmaline Bio, Inc.
Summary company analysis:Tourmaline Bio, Inc.
Selecting high-quality issuers is based on profit dynamics, where fundamental analysis requires assessing the real profitability of the business by comparing current earnings per share with the same period last year. By analyzing the earnings per share growth rates over 12 months, an investor can see the effectiveness of the biopharmaceutical developments of Tourmaline Bio, Inc. (TRML), including the impact of costs associated with implementing green standards and energy-saving systems in laboratories.
Main competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|GRFS: Net earnings per share growth this year|Adaptive Biotechnologies Inc. - Net earnings per one share growth for the current year|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Earnings per share growth rate in current year auriniapharma.com (AUPH)|Net earnings per share growth this year BCRX|Earnings growth in current year Vera Therapeutics Inc|Earnings per share growth in current year Dianthus Pharma (DNTH)|PHVS (Pharvaris Pharma) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera Biologics ABCL|PGEN - Net earnings per share growth this year|Pharming Group - Earnings growth in current year|NKTR - Earnings growth in current year|Upstream Bio Corp (UPB) - Earnings per share growth in current year|ZBIO (Zenas Corp) - Earnings per share growth in current year|IMNM (Immunome, Inc.) - Earnings growth in current year|gossamerbio.com (GOSS) - Expected net earnings per share growth this year|Earnings per share growth in current year KalVista Pharmaceuticals, Inc. (KALV)|Septerna, Inc. - Earnings per share growth this year|Earnings growth in current year PVLA (Pieris Pharmaceuticals Inc)|Savara Pharma (SVRA) - Earnings per share growth rate in current year|RIGL: Net earnings per share growth this year|Earnings per share increase in current year ANAB (anaptysbio.com)|ATXS: Earnings growth in current year|ENGN (enGene Holdings Inc) - Earnings per share growth in current year|RAPT (RAPT Therapeutics) - Earnings growth in current year|Aerovate (JBIO) - Expected net earnings per share growth this year|Earnings per share growth in current year Aclaris Therapeutics (ACRS)|KYTX - Earnings per share growth rate in current year|Tiziana Life Sciences Ltd - Net earnings per share growth this year|Earnings per share increase in current year CABA|Ventyx Bio - Earnings growth in current year|Expected net earnings per share growth this year Theratechnologies, Inc THTX|Avalo Therapeutics, Inc (AVTX) - Earnings per share growth in current year|Earnings per share growth this year ELDN|AGEN (Agenus Inc.) - Earnings growth in current year|Net earnings per share growth this year Climb Bio Inc. (CLYM)|Net earnings per share growth this year ZURA (Zura Bio)|Expected net earnings per share growth this year aTyr Pharmaceuticals|Adagene Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year IMA (ImageneBio)|STTK - Earnings per share growth in current year|Earnings per share increase in current year EQ (Equillium, Inc.)|connectbiopharm.com (CNTB) - Earnings per share growth in current year|Net earnings per share growth this year Immunic|Earnings per share growth in current year Atara Biotherapeutics, Inc.|Earnings per share growth in current year IFRX|Earnings per share growth in current year X4 Pharmaceuticals, Inc. (XFOR)|ACET: Earnings per share trend in current year|Earnings growth in current year CELU (Celularity)|Earnings per share increase in current year INMB|Barinthus Biotherapeutics - Earnings growth in current year|KZR - Earnings growth in current year|SAB Biotherapeutics, Inc. (SABS) - Earnings per share growth in current year|Akari Therapeutics PLC - Earnings per share increase in current year|Earnings per share growth in current year Enlivex Therapeutics Ltd|Net earnings per share growth this year Q32 Bio Corp (QTTB)|Earnings growth in current year GOVX|Earnings growth in current year edesabiotech.com (EDSA)|iBio - Net earnings per share growth this year|Earnings per share increase in current year CARM|XTL Biopharmaceuticals, Ltd. - Earnings growth in current year|Expected net earnings per share growth this year Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo Therapeutics Inc.|Earnings per share growth in current year AIM ImmunoTech Inc.|Net earnings per share growth this year Aditxt Corp (ADTX)|Net earnings per share growth this year GRI (GRI Bio Corp)|Earnings growth in current year XORTX Corp (XRTX)|Earnings per share growth in current year Vyome Holdings Inc HIND|REVB: Earnings per share growth this year|Indaptus Therapeutics, Inc. - Earnings growth in current year|Earnings per share growth rate in current year Scinai Immunotherapeutics Ltd|CALI (calcimedica.com) - Net earnings per share growth this year|AFMD: Net earnings per one share growth for the current year|Earnings per share growth in current year Allakos Inc|Earnings per share growth rate in current year HOOKIPA HOOK|Net earnings per share growth this year IGMS (IGM Biosciences, Inc.)|Earnings growth in current year iTeos Therapeutics Inc (ITOS)|Earnings per share growth in current year Ocean Bio OCEA|Earnings per share increase in current year TCBP|THRD - Earnings per share growth in current year
